Follow the latest news updates on the Sean "Diddy" Combs trial. Defense hammers ex-assistant for posts supporting Combs after alleged assaults.

Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a open-label study ...

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

Jasper Therapeutics’ stock has dropped by more than 50% after the company announced it was looking into the impact of a ...

Topline data expected in H2 2026 LONDON and CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited ("Beacon Therapeutics" or "the Company"), a leading clinical-stage ...

Sirtex Medical’s SIR-Spheres Y-90 resin microspheres receive US FDA nod to treat unresectable hepatocellular carcinoma: Woburn, Massachusetts Tuesday, July 8, 2025, 17:00 Hrs [I ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 1500 Health Care Index returned 5.5% in the first quarter, ...

Top-line results for the last cohort of patients in the Phase 2a clinical trial in mild-to-moderate psoriasis with SGX302 (synthetic hypericin) in 4Q 2025, where we have already demonstrated the ...

In an open-label trial conducted in Switzerland, pregnant women with gestational diabetes were randomly assigned to Dexcom G6 real-time CGM or self-monitoring blood glucose for the duration of ...

Surprised to hear us recommend pants your pops swears by? You shouldn’t be. In fact, their righteous, anti-fashion dadliness ...

Submission is based on long-term Phase 3 data demonstrating 63 percent reduction in risk of relapse in adults with schizophrenia compared to placebo CAPLYTA® is FDA ...

SEAN “Diddy” Combs’ twin girls Jessie and D’Lila have released a clothing line just days after their father was convicted.